CY1106577T1 - Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος - Google Patents

Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος

Info

Publication number
CY1106577T1
CY1106577T1 CY20071100632T CY071100632T CY1106577T1 CY 1106577 T1 CY1106577 T1 CY 1106577T1 CY 20071100632 T CY20071100632 T CY 20071100632T CY 071100632 T CY071100632 T CY 071100632T CY 1106577 T1 CY1106577 T1 CY 1106577T1
Authority
CY
Cyprus
Prior art keywords
acid derivatives
delivery system
aminolebulinic
cutaneous delivery
cutaneous
Prior art date
Application number
CY20071100632T
Other languages
English (en)
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Ulrich Kosciessa
Original Assignee
Photonamic Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co. Kg filed Critical Photonamic Gmbh & Co. Kg
Publication of CY1106577T1 publication Critical patent/CY1106577T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ένα δερματικό σύστημα χορήγησης για παράγωγα αμινολεβουλινικού οξέος, το οποίο πρόκειται για ένα αυτοκόλλητο σύστημα μήτρας, το οποίο περιέχει κρυσταλλικά παράγωγα αμινολεβουλινικού οξέος.
CY20071100632T 2002-01-23 2007-05-10 Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος CY1106577T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10202487A DE10202487A1 (de) 2002-01-23 2002-01-23 Dermales Applikationssystem für Aminolävulinsäure-Derivate
PCT/EP2003/000406 WO2003061621A2 (de) 2002-01-23 2003-01-16 Dermales applikationssystem für aminolävulinsäure-derivate

Publications (1)

Publication Number Publication Date
CY1106577T1 true CY1106577T1 (el) 2012-01-25

Family

ID=7712859

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100632T CY1106577T1 (el) 2002-01-23 2007-05-10 Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος

Country Status (13)

Country Link
US (1) US8465762B2 (el)
EP (1) EP1467706B1 (el)
JP (1) JP2005521654A (el)
AT (1) ATE356610T1 (el)
AU (1) AU2003206734B2 (el)
CY (1) CY1106577T1 (el)
DE (2) DE10202487A1 (el)
DK (1) DK1467706T3 (el)
ES (1) ES2281621T3 (el)
NO (1) NO333423B1 (el)
PT (1) PT1467706E (el)
SI (1) SI1467706T1 (el)
WO (1) WO2003061621A2 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
EP1877509B1 (en) 2005-03-17 2011-10-12 Pharmafilm S.R.L. An aqueous polymeric system for pressure sensitive adhesive matrix preparation
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
EP2590714B1 (en) * 2010-07-09 2017-03-08 Photocure ASA Devices containing dry compositions for use in photodynamic therapy
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
US10834094B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Operator action authentication in an industrial control system
US11967839B2 (en) 2011-12-30 2024-04-23 Analog Devices, Inc. Electromagnetic connector for an industrial control system
US9727511B2 (en) 2011-12-30 2017-08-08 Bedrock Automation Platforms Inc. Input/output module with multi-channel switching capability
US9600434B1 (en) 2011-12-30 2017-03-21 Bedrock Automation Platforms, Inc. Switch fabric having a serial communications interface and a parallel communications interface
US11314854B2 (en) 2011-12-30 2022-04-26 Bedrock Automation Platforms Inc. Image capture devices for a secure industrial control system
US8868813B2 (en) 2011-12-30 2014-10-21 Bedrock Automation Platforms Inc. Communications control system with a serial communications interface and a parallel communications interface
US8971072B2 (en) 2011-12-30 2015-03-03 Bedrock Automation Platforms Inc. Electromagnetic connector for an industrial control system
US9437967B2 (en) 2011-12-30 2016-09-06 Bedrock Automation Platforms, Inc. Electromagnetic connector for an industrial control system
US9467297B2 (en) 2013-08-06 2016-10-11 Bedrock Automation Platforms Inc. Industrial control system redundant communications/control modules authentication
US11144630B2 (en) 2011-12-30 2021-10-12 Bedrock Automation Platforms Inc. Image capture devices for a secure industrial control system
US10834820B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Industrial control system cable
US9191203B2 (en) 2013-08-06 2015-11-17 Bedrock Automation Platforms Inc. Secure industrial control system
US8862802B2 (en) 2011-12-30 2014-10-14 Bedrock Automation Platforms Inc. Switch fabric having a serial communications interface and a parallel communications interface
IN2015DN00837A (el) 2012-08-03 2015-06-12 Photocure Asa
US10613567B2 (en) 2013-08-06 2020-04-07 Bedrock Automation Platforms Inc. Secure power supply for an industrial control system
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
KR200483745Y1 (ko) 2017-02-16 2017-06-19 김태완 자동차 매너 클락션 장치
US11903723B2 (en) 2017-04-04 2024-02-20 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (el) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
MX9504023A (es) 1994-09-20 1997-05-31 Johnson & Johnson Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
AU7127196A (en) * 1995-09-21 1997-04-09 Novartis Ag Nanoparticles in photodynamic therapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
CN1240384C (zh) * 1999-11-04 2006-02-08 美国爱科赛尔制药有限公司 石杉碱经皮给药制剂
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
NZ533107A (en) * 2001-11-08 2007-04-27 Upjohn Co N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives

Also Published As

Publication number Publication date
US8465762B2 (en) 2013-06-18
WO2003061621A3 (de) 2003-12-31
DE50306796D1 (de) 2007-04-26
EP1467706A2 (de) 2004-10-20
NO20034214D0 (no) 2003-09-22
US20060018956A1 (en) 2006-01-26
ATE356610T1 (de) 2007-04-15
NO20034214L (no) 2003-11-24
AU2003206734B2 (en) 2007-09-06
JP2005521654A (ja) 2005-07-21
SI1467706T1 (sl) 2007-06-30
DE10202487A1 (de) 2003-07-31
WO2003061621A2 (de) 2003-07-31
EP1467706B1 (de) 2007-03-14
DK1467706T3 (da) 2007-07-09
ES2281621T3 (es) 2007-10-01
PT1467706E (pt) 2007-03-30
NO333423B1 (no) 2013-06-03

Similar Documents

Publication Publication Date Title
CY1106577T1 (el) Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
CY1107236T1 (el) Παραγωγα της 2-αμινο-3-(αλκυλο)-πυριμιδονης ως gsk3. βητα αναστολεις
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
ATE464041T1 (de) Zusammensetzung zur hautaufhellung
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
NO20053663D0 (no) Transdermal granistetron
CY1106752T1 (el) Διϋδροπτεριδινονες, μεθοδος για την παραγωγη τους και χρηση τους ως φαρμακων
BRPI0413973A (pt) compostos
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CY1112185T1 (el) Σταθερο συμπλοκο δραστικων ουσιων απο αλατα των o-ακετυλοσαλικυλικων οξεων με βασικα αμινοξεα και γλυκινη
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
ECSP045215A (es) Metabolitos del ácido (3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acético
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
UY27612A1 (es) Sales estables del ácido o-acetilsalicílico con aminoácidos básicos l l
PL376130A1 (en) Controlled releases system containing temozolomide
CY1110782T1 (el) Αλατα προσθηκης αναστολεων του ενζυμου μετατροπης της αγγειοτασινης με οξεα δοτες no, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας
PT1357932E (pt) Modificacao cristalina de um depsipeptido ciclico com eficacia melhorada